JD Health International Inc. announced the simultaneous termination of its existing contractual arrangements and execution of a new set of contracts governing Suqian Jingdong Tianning Jiankang Technology Co., Ltd. (“Suqian Tianning”). The change was triggered by a 30% equity transfer in Suqian Tianning from former shareholder Ms. Yayun Li to Ms. Tingting Sui, a vice-president of JD Group, on 26 March 2026. The remaining equity stakes—45% held by Mr. Qin Miao and 25% by Ms. Pang Zhang—remain unchanged.
Under the new contractual arrangements—substantially identical to the prior structure—Beijing Jingdong Jiankang Co., Ltd. (the wholly-owned PRC subsidiary, “WFOE”) retains: • an Exclusive Business Cooperation Agreement entitling it to 100% of Suqian Tianning’s adjusted net profit; • an Exclusive Option Agreement allowing purchase of all equity or assets at nominal consideration when PRC regulation permits; • a Share Pledge Agreement securing the shareholders’ equity as collateral; • a Shareholders’ Rights Entrustment Agreement and irrevocable powers of attorney ensuring WFOE’s control over all shareholder rights; and • a Loan Agreement totaling RMB1 million to the registered shareholders for Suqian Tianning’s capitalization.
JD Health’s PRC legal counsel confirmed the new agreements are valid, binding and compliant with current PRC law, though it cautioned that future regulatory interpretations could differ. The company’s auditors affirmed Suqian Tianning will continue to be fully consolidated into JD Health’s financial statements under IFRS.
Listing Rules implications remain unchanged. Because Suqian Tianning’s financials will still be consolidated, its individual shareholders are deemed connected persons. However, the Hong Kong Stock Exchange reconfirmed that the transactions fall within the scope of the existing IPO Waiver, exempting JD Health from independent shareholders’ approval, annual caps and the three-year term limit usually required for continuing connected transactions.
The board stated the restructuring aims to enhance administrative efficiency, given Ms. Sui’s Beijing base, and concluded that the new contractual arrangements are fair, reasonable and in the interests of all shareholders. No director abstained from voting on the resolution.
Key risks highlighted include potential future PRC policy shifts that could invalidate VIE structures, reliance on contractual performance by Suqian Tianning’s shareholders and possible tax scrutiny. The company reported no interference by PRC authorities to date under either the previous or new arrangements.
Comments